MarketPeel
Insider Trading Intelligence
SK

Sherry Korczynski

AQST
SVP SALES AND MARKETING · AQUESTIVE THERAPEUTICS, INC. · CIK 0002026090
FILING MIX · LIFETIME64%/36%
BUYS
7
SELLS
4
TOTAL VALUE
$272.0K
COMPANIES
1
ACTIVE SINCE
Jun 2024
HOLDINGS NOW
238,403
AVG SELL PX
$3.75
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Sherry Korczynski, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-2.14%-0.94%-1.20%-1.20%
14d1+100.00%-7.62%-3.54%-4.08%-4.08%
30d1+100.00%-0.71%+0.40%-1.12%-1.12%
60d1+0.00%+2.86%+8.93%-6.07%-6.07%
90d1+100.00%-6.43%+8.90%-15.33%-15.33%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AQST · 238,403 shares · as of Jun 8, 2026
064,215128,429192,644256,85820252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 7 buys / 4 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Commercial Officer
2,714238,403Jun 8, 2026Jun 10, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
Chief Commercial Officer
15,741$4.17$65.7K241,117Mar 10, 2026Mar 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,500$4.29$182.3K42,500Mar 9, 2026Mar 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,000256,858Mar 9, 2026Mar 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000181,858Aug 14, 2025Aug 15, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
SVP Sales and Marketing
2,714$3.54$9.6K156,858Jun 9, 2025Jun 10, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
67,50067,500Mar 7, 2025Apr 13, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
SVP Sales and Marketing
5,428$2.65$14.4K159,572Mar 7, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,000165,000Mar 7, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,00035,000Mar 7, 2025Mar 11, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 7, 2024Jun 11, 2024View →
Other insiders · AQST
Loading peer insiders…
About this filer
CIK 0002026090
ROLE
SVP Sales and Marketing
PRIMARY
AQST
COMPANIES
1
ACTIVE SINCE
Jun 2024
MARKETPEEL · /INSIDER/0002026090DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback